New insulin put to the test against market leaders in healthy volunteers

This study compared a new insulin called NKF-INS(L) with two already-approved insulins (US-Humalog and EU-Humalog) in 54 healthy men. The goal was to see if the new insulin is absorbed and works similarly in the body. Participants received a single dose of each insulin in random order, and researchers measured blood sugar and insulin levels using a special technique. The study did not treat any disease, but helps confirm whether the new insulin can be used in future diabetes treatments.